Abstract
705 Prophylasix of Post-ERCP Pancreatitis With Nafamostat Mesilate: Comparison of 24-Hour and 8-Hour Infusion of Nafamostat Mesilate: a Prospective Randomized Comparison Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have